Page 346 - ACCCN's Critical Care Nursing

Cardiac Surgery and Transplantation 323

50. Elahi MM, Chetty GK, Kirke R, Azeem T et al. Complications related to intra- 76. Doughty R, Yee T, Sharpe N, MacMahon S. Hospital admissions and deaths
aortic balloon pump in cardiac surgery: a decade later. Eur J Vasc Endovasc due to congestive heart failure in New Zealand, 1988–91. NZ Med J 1995;
Surg 2005; 29(6): 591–4. 108(1012): 473–5.
51. Meco M, Gramegna G, Yassini A et al. Mortality and morbidity from intra- 77. Garg R, Packer M, Pitt B, Yusuf S. Heart failure in the 1990s: evolution of a
aortic balloon pumps: risk analysis. J Cardiovasc Surg 2002; 43(1): 17–23. major public health problem in cardiovascular medicine. J Am Coll Cardiol
52. Krau SD. Successfully weaning the intra-aortic balloon pump patient: an 1993; 22(4 Suppl A): 3A–5A.
algorithm. Dimens Crit Care Nurs 1993; 18(3): 2–11. 78. Australian Institute of Health and Welfare. Heart, stroke and vascular disease:
53. Chapman JR. Transplantation in Australia – 50 years in progress. Med J Aust Australian Facts 2001. Perth: Australian Institute of Health and Welfare,
1992; 157(1): 46–50. National Heart Foundation and National Stroke Foundation of Australia;
54. McBride M, Chapman JR. An overview of transplantation in Australia. 2001.
Anaesth Intens Care 1995; 23(1): 60–64. 79. Kirklin JK, Young JB, McGiffin DC. Heart transplantation. Philadelphia:
55. Borel JF, Feurer C, Gubler HU, Stahelin H. Biological effects of cyclosporin-A: Churchill Livingstone; 2002.
a new antilymphocytic agent. Agents Actions 1976; 6(4): 468–75. 80. Angermann CE, Spes CH, Tammen A, Stempfle HU, Schutz A et al. Anatomic
56. Barnard CN. A human cardiac transplant: an interim report of a successful characteristics and valvular function of the transplanted heart: transthoracic
operation performed at Groote Schuur Hospital, Capetown. S Afr Med J versus transesophageal echocardiographic findings. J Heart Transplant 1990;
1967; 41(48): 1271–4. 9(4): 331–8.
57. Oyer PE, Stinson EB, Jamieson SA et al. Cyclosporin A in cardiac allografting: 81. Kendall SWH, Ciulli F, Mullins PA, Biocina B, Dunning JJ, Large SR. Total
a preliminary experience. Transplant Proc 1983; 15: 1247–52. orthotopic heart transplantation: An alternative to the standard technique.
58. Excell L, Hee K, Russ GR. Australia and New Zealand organ donation registry Ann Thorac Surg 1992; 54(1): 187–92.
2010. [Cited Sept 2010]. Available from: http://www.anzdata.org.au/anzod/ 82. Dreyfus G, Jebara V, Mihaileanu S, Carpentier AF. Total orthotopic heart
ANZODReport/2010/2010Contents.pdf transplantation: an alternative to the standard technique. Ann Thorac Surg
59. Rose EA, Moskowitz AJ, Packer M, Sollano JA, Williams DL et al. The 1991; 52(5): 1181–4.
REMATCH trial: rationale, design, and end points. Randomized evaluation 83. International Society for Heart Lung Transplantation (ISHLT) Transplant
of mechanical assistance for the treatment of congestive heart failure. Ann Registry Quarterly Reports for Heart in Australasia. 2004 [Cited Dec 2004].
Thorac Surg 1999; 67(3): 723–30. Available from: http://www.ishlt.org.
60. Mason VF, Konicki AJ. Left ventricular assist devices as destination therapy. 84. Nakatani T, Frazier OH, Lammermeier DE, Marcis MP, Radovancevic
AACN Clin Iss 2003; 14(4): 488–97. B. Heterotopic heart transplantation: a reliable option for a select group of
61. Hertz MI, Aurora P, Christie JD, Dobbels F, Edwards LB et al. Scientific high-risk patients. J Heart Lung Transplant 1989; 8(1): 40–47.
Registry of the International Society for Heart and Lung Transplantation: 85. Newcomb AE, Esmore DS, Rosenfeldt FL, Richardson M, Marasco SF. Het-
Introduction to the 2009 Annual Reports. J Heart Lung Transplantation, 2009; erotopic heart transplantation: an expanding role in the twenty-first century?
28(4): 989–92. Ann Thorac Surg 2004; 78(4): 1345–50.
62. National Heart Foundation. Heart transplants and organ donation 86. Neerukonda SK, Schoonmaker FW, Nampalli VK, Narrod JA. Ventricular
[Cited Sept 2010]. Available from: http://www.heartfoundation.org.au/ dysrthythmia and heterotopic heart transplantation. J Heart Lung Transplant
SiteCollectionDocuments/A_HeartTransplantsDonations_ISC_FINAL.pdf 1992; 11(4 Pt 1): 793–6.
63. Organ Donation New Zealand [Cited Sept 2010]. Available from: http:// 87. Bridges EJ. Monitoring pulmonary artery pressures: just the facts. Crit Care
www.donor.co.nz/donor/transplants/success_rates.php Nurse 2000; 20(6): 59–78.
64. Keogh A, Pettersson R. Australia and New Zealand Cardiothoracic Organ 88. Cathelyn J. Avoiding respiratory excursions: obtaining reliable pulmonary
Transplant Registry: 2008 Report. Darlinghurst: Australia and New Zealand capillary wedge pressures. Dimens Crit Care Nurs 1997; 16(1): 2–7.
Cardiothoracic Organ Transplant Registry; 2008. 89. Sommers MS, Woods SL, Courtade MA. Issues in methods and measurement
65. Taylor DO, Stehlik J, Edwards LB et al. Registry of the international society of thermodilution cardiac output. Nurs Res 1993; 42(4): 228–33.
for heart and lung transplantation: twenty-sixth official adult heart 90. Busauschina A, Schnuelle P, van der Woude FJ. Cyclosporine nephrotoxicity.
transplant report 2009. J Heart Lung Transplant 2009; 28(10): 1007–22. Transplant Proc 2004; 36(2 Suppl): S229S–33.
66. Mehra MR, Kobashigawa J, Starling R et al. Listing criteria for heart 91. Serkova NJ, Christians U, Benet LZ. Biochemical mechanisms of cyclospo-
transplantation: International Society for Heart and Lung Transplantation rine neurotoxicity. Mol Interv 2004; 4(2): 97–107.
guidelines for the care of cardiac transplant candidates, 2006. J Heart Lung 92. Trento A, Hardesty RL, Griffith BP, Zerbe T, Kormos RL, Bahnson HT. Role
Transplant 2006; 25(9): 1024–42. of the antibody to vascular endothelial cells in hyperacute rejection in
67. Russo MJ, Chen JM, Hong KN et al. Survival after heart transplantation is patients undergoing cardiac transplantation. J Thorac Cardiovasc Surg 1988;
not diminished among recipients with uncomplicated diabetes mellitus: an 95(1): 37–41.
analysis of the United Network of Organ Sharing database. Circulation 2006; 93. Stevenson LW, Miller LW. Cardiac transplantation as therapy for heart failure.
114(21): 2280–87. Curr Probl Cardiol 1991; 16(4): 217–305.
68. Grady KL, White-Williams C, Naftel D et al. Are preoperative obesity and 94. Hammond EH. Pathology of cardiac allograft rejection. In: Cooper DKC,
cachexia risk factors for post heart transplant morbidity and mortality: a Miller LW, Patterson GA, eds. The transplantation and replacement of thoracic
multi-institutional study of preoperative weight-height indices. Cardiac organs, 2nd edn. Boston: Kluwer; 1996: 239–52.
Transplant Research Database (CTRD) Group. J Heart Lung Transplant 1999; 95. Laufer G, Laczkovics A, Wollenek G, Buxbaum P, Seitelberger R et al. The
18(8): 750–63. progression of mild acute cardiac rejection evaluated by risk factor analysis:
69. Chacko RC, Harper RG, Gotto J et al. Psychiatric interview and psychometric the impact of maintenance steroids and serum creatinine. Transplantation
predictors of cardiac transplant survival. Am J Psychiatry 1996; 153(12): 1991; 51(1): 184–9.
1607–12. 96. Caves PK, Stinson EB, Billingham ME, Rider AK, Shumway NE. Diagnosis of
70. Shapiro PA, Williams DL, Foray AT et al. Psychosocial evaluation and predic- human cardiac allograft rejection by serial cardiac biopsy. J Thorac Cardiovasc
tion of compliance problems and morbidity after heart transplantation. Surg 1973; 66(3): 461–6.
Transplantation 1995; 60(12): 1462–6. 97. Billingham ME, Cary NR, Hammond ME, Kemnitz J, Marboe C et al.
71. Macdonald P. Heart transplantation: who should be considered and when? A working formulation for the standardization of nomenclature in the diag-
Intern Med J 2008; 38(12): 911–17. nosis of heart and lung rejection: Heart Rejection Study Group. International
72. The Transplantation Society of Australia and New Zealand. Eligibility guide- Society for Heart Transplantation. J Heart Transplant 1990; 9(6): 587–93.
lines and allocation protocols; Draft, 22 March 2010. Available from: http:// 98. Lloveras JJ, Escourrou G, Delisle MB, Fournial G, Cerene A et al. Evolution
www.tsanz.com.au/organallocationprotocols/downloads/TSANZ%20 of untreated mild rejection in heart transplant recipients. J Heart Lung
Elibility%20and%20Allocation%202nd%20Draft.pdf Transplant 1992; 11(4 Pt 1): 751–6.
73. Clark RA, McLennan S, Dawson A, Wilkinson D, Stewart S. Uncovering a 99. Olsen SL, Wagoner LE, Hammond EH, Taylor DO, Yowell RL et al. Vascular
hidden epidemic: A study of the current burden of heart failure in Australia. rejection in heart transplantation: clinical correlation, treatment options,
Heart, Lung Circ 2004; 13(2): 166–73. and future considerations. J Heart Lung Transplant 1993; 12(2): S135–42.
74. Chronic Heart Failure Working Party. Hospital admission risk program (HARP): 100. Partanen J, Nieminen MS, Krogerus L, Harjula AL, Mattila S. Heart transplant
chronic heart failure working group report. Melbourne: Victorian Government rejection treated with plasmapheresis. J Heart Lung Transplant 1992; 11
Department of Human Services; 2003. (2 Pt 1): 301–5.
75. Australian Institute of Health and Welfare. Australia’s Health 2008. Canberra: 101. Taylor DO. Cardiac transplantation: Drug regimens for the 21st century.
AIHW; Report No. 11. Ann Thorac Surg 2003;75(6 Suppl): S72–8.